OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL)

CUSIP: 67576A100

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
214,467,875
Total 13F shares
39,773,072
Share change
+1,081,456
Total reported value
$302,720,116
Put/Call ratio
119%
Price per share
$7.61
Number of holders
101
Value change
+$7,274,447
Number of buys
51
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q3 2020

As of 30 Sep 2020, OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,773,072 shares. The largest 10 holders included Opaleye Management Inc., SUMMER ROAD LLC, BlackRock Inc., VANGUARD GROUP INC, RA CAPITAL MANAGEMENT, L.P., DELTEC ASSET MANAGEMENT LLC, Versant Venture Management, LLC, Ikarian Capital, LLC, CITADEL ADVISORS LLC, and STATE STREET CORP. This page lists 101 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.